PARKMAN HEALTHCARE PARTNERS LLC – Neurocrine Biosciences, Inc. Transaction History
PARKMAN HEALTHCARE PARTNERS LLC portfolio value:
$12.46M
portfolio value
PARKMAN HEALTHCARE PARTNERS LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +37.17% | 31.81K shares | 4.12M | $106.21 | 117.4K |
| Q2 2022 | share | Increase | +35.35% | 22.35K shares | 2.41M | $97.48 | 85.58K |
| Q1 2022 | share | Increase | 0.00% | 63.23K shares | 5.92M | $93.75 | 63.23K |
| Q4 2020 | share | Decrease | -100.00% | -132.54K shares | -12.74M | $95.85 | 0 |
| Q3 2020 | share | Increase | +9.07% | 11.01K shares | -2.08M | $96.16 | 132.54K |
| Q2 2020 | share | Decrease | -5.45% | -7K shares | 3.70M | $122 | 121.52K |
| Q1 2020 | share | Decrease | -17.31% | -26.89K shares | -5.58M | $86.55 | 128.52K |
| Q4 2019 | share | Increase | 0.00% | 155.42K shares | 16.70M | $107.49 | 155.42K |